Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia
| Title: | Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia |
|---|---|
| Authors: | Gil-Rojas, Yaneth; Lasalvia, Pieralessandro; García, Ángel |
| Contributors: | AstraZeneca Colombia |
| Source: | Expert Review of Pharmacoeconomics & Outcomes Research ; volume 22, issue 4, page 655-663 ; ISSN 1473-7167 1744-8379 |
| Publisher Information: | Informa UK Limited |
| Publication Year: | 2021 |
| Document Type: | article in journal/newspaper |
| Language: | English |
| DOI: | 10.1080/14737167.2022.1997595 |
| Availability: | https://doi.org/10.1080/14737167.2022.1997595; https://www.tandfonline.com/doi/pdf/10.1080/14737167.2022.1997595 |
| Rights: | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Accession Number: | edsbas.5C9FA6DB |
| Database: | BASE |